AbbVie Inc.

NYSE-ABBV

Assets	LTM	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
Cash and Cash Equivalents	5,629	5,524	12,814	9,201	9,746	8,449	39,924	7,289	9,303	5,100	8,399
Cash and Equivalents
Short-Term Investments	42	31	2	28	84	30	—	772	486	1,323	8
Short-Term Investments
Total Cash and Cash Equivalents	5,671	5,555	12,816	9,229	9,830	8,479	39,924	8,061	9,789	6,423	8,407
Accounts Receivable	12,769	10,919	11,155	11,254	9,977	8,822	5,428	5,384	5,088	4,758	4,730
Accounts Receivable, Net
Total Trade Receivables	12,769	10,919	11,155	11,254	9,977	8,822	5,428	5,384	5,088	4,758	4,730
Inventories	4,938	4,181	4,099	3,579	3,128	3,310	1,813	1,605	1,605	1,444	1,719
Inventories
Other Current Assets	5,161	4,927	4,932	4,401	4,993	3,562	2,354	1,895	4,741	3,562	1,458
Income Tax Receivable
Deferred Income Taxes
Prepaid Expenses and Other
Total Current Assets	28,539	25,582	33,002	28,463	27,928	24,173	49,519	16,945	21,223	16,187	16,314
Total Current Assets
Net Property, Plant & Equipment	5,483	5,134	4,989	4,935	5,110	5,248	2,962	2,883	2,803	2,604	2,565
Property and Equipment, Net
Net Intangible Assets	54,315	60,068	55,610	67,439	75,951	82,876	18,649	21,233	27,559	28,897	19,709
Intangible Assets, Net
Goodwill	35,626	34,956	32,293	32,156	32,379	33,124	15,604	15,663	15,785	15,416	13,168
Goodwill
Long-Term Investments	291	279	304	241	277	293	93	1,420	2,090	1,783	145
Investments
Other Long-Term Assets	9,644	9,142	8,513	5,571	4,884	4,851	2,288	1,208	1,326	1,212	1,149
Other Assets
Total Assets	133,898	135,161	134,711	138,805	146,529	150,565	89,115	59,352	70,786	66,099	53,050
Total Assets

Liabilities	LTM	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
Accounts Payable	33,619	31,945	30,650	25,402	22,699	20,159	11,832	11,931	10,226	9,379	8,463
Accounts Payable and Accrued Liabilities
Short-Term Debt	3,790	—	—	1	14	34	—	3,699	400	377	406
Short-Term Borrowings
Current Portion of Long-Term Debt	1,982	6,804	7,191	4,135	12,481	8,468	3,753	1,609	6,015	25	2,025
Current Portion of Long-Term Debt and Finance Lease Obligations
Total Current Liabilities	39,391	38,749	37,841	29,538	35,194	28,661	15,585	17,239	16,641	9,781	10,894
Total Current Liabilities
Long-Term Debt	62,971	60,340	52,194	59,135	64,189	77,554	62,975	35,002	30,953	36,440	29,240
Long-Term Debt and Finance Lease Obligations
Other Long-Term Liabilities	34,135	32,708	34,279	32,845	31,710	31,253	18,727	15,557	18,095	15,242	8,971
Deferred Income Taxes
Other Long-Term Liabilities
Total Long-Term Liabilities	97,106	93,048	86,473	91,980	95,899	108,807	81,702	50,559	49,048	51,682	38,211
Total Long-Term Liabilities
Total Liabilities	136,497	131,797	124,314	121,518	131,093	137,468	97,287	67,798	65,689	61,463	49,105

Equity	LTM	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
Common Stock	18	18	18	18	18	18	18	18	18	18	17
Common Stock
Treasury Stock	-9,143	-8,201	-6,533	-4,594	-3,143	-2,264	-24,504	-24,108	-11,923	-10,852	-8,839
Common Stock Held in Treasury, at Cost
Additional Paid-in Capital	22,291	21,333	20,180	19,245	18,305	17,384	15,193	14,756	14,270	13,678	13,080
Additional Paid-in Capital
Accumulated Other Comprehensive Income	-1,574	-1,925	-2,305	-2,199	-2,899	-3,117	-3,596	-2,480	-2,727	-2,586	-2,561
Accumulated Other Comprehensive Loss
Retained Earnings	-14,234	-7,900	-1,000	4,784	3,127	1,055	4,717	3,368	5,459	4,378	2,248
Retained Earnings
Net Parent Company Investment in AbbVie Inc., Prior to Separation
Total Common Shareholders' Equity	-2,642	3,325	10,360	17,254	15,408	13,076	-8,172	-8,446	5,097	4,636	3,945
Total Stockholders' Equity
Minority Interests and Other	43	39	37	33	28	21	—	—	—	—	—
Noncontrolling Interest
Total Shareholders' Equity	-2,599	3,364	10,397	17,287	15,436	13,097	-8,172	-8,446	5,097	4,636	3,945
Total Equity
Total Parent Company Equity
Total Liabilities and Shareholders' Equity	133,898	135,161	134,711	138,805	146,529	150,565	89,115	59,352	70,786	66,099	53,050
Total Liabilities and Equity